News

Labor induction, augmentation may be tied to autism risk


 

FROM JAMA PEDIATRICS

Exposure to endogenous oxytocin during labor also may affect as yet unidentified genetic factors. For example, they recently found that the promoter region of the oxytocin receptor gene exhibits differential methylation in autistic than in control populations, Dr. Gregory and his associates said.

"Our results suggest the need for further research focusing on the association of labor induction/ augmentation with autism..."

This study was limited in that the birth registry didn’t include data concerning all the possible factors that could influence neonatal neurologic injury; it was missing information such as prenatal and intrapartum medication exposures and certain labor abnormalities, they noted.

In addition, the school data didn’t provide details about "where a child lay on the autism spectrum," so "the estimated associations represent an average effect over varying degrees of autism presentation."

"In conclusion ... our results suggest the need for further research focusing on the association of labor induction/augmentation with autism," the investigators said.

This study was funded in part by the U.S. Environmental Protection Agency. No financial conflicts of interest were reported.

Pages

Recommended Reading

Subjective cognitive decline may be early omen of Alzheimer’s
MDedge Family Medicine
Two-minute Alzheimer’s test? Not so fast!
MDedge Family Medicine
Food for thought: DASH diet slowed cognitive decline
MDedge Family Medicine
Brain atrophy rate may predict later cognitive decline
MDedge Family Medicine
Glucose, insulin measures unrelated to AD pathology
MDedge Family Medicine
Aerobic exercise boosts brain power in mild cognitive impairment
MDedge Family Medicine
Learning genetic risk for Alzheimer’s may not be so distressing
MDedge Family Medicine
Higher glucose linked to increased dementia risk
MDedge Family Medicine
New drug matched donepezil’s efficacy in mild to moderate Alzheimer’s
MDedge Family Medicine
Alzheimer’s biomarkers have limited use in diagnosing frontotemporal dementia
MDedge Family Medicine